AlphaQuest LLC Boosts Position in Core Laboratories Inc. $CLB

AlphaQuest LLC increased its holdings in shares of Core Laboratories Inc. (NYSE:CLB) by 265,800.0% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 2,659 shares of the oil and gas company’s stock after purchasing an additional 2,658 shares during the quarter. AlphaQuest LLC’s holdings in Core Laboratories were worth $40,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Dimensional Fund Advisors LP lifted its stake in Core Laboratories by 3.5% in the fourth quarter. Dimensional Fund Advisors LP now owns 847,983 shares of the oil and gas company’s stock valued at $14,678,000 after buying an additional 28,393 shares during the last quarter. Northern Trust Corp lifted its stake in Core Laboratories by 15.6% in the fourth quarter. Northern Trust Corp now owns 577,752 shares of the oil and gas company’s stock valued at $10,001,000 after buying an additional 78,173 shares during the last quarter. Fred Alger Management LLC lifted its stake in Core Laboratories by 3.8% in the fourth quarter. Fred Alger Management LLC now owns 556,509 shares of the oil and gas company’s stock valued at $9,633,000 after buying an additional 20,596 shares during the last quarter. Envestnet Asset Management Inc. lifted its stake in Core Laboratories by 1.3% in the first quarter. Envestnet Asset Management Inc. now owns 254,005 shares of the oil and gas company’s stock valued at $3,808,000 after buying an additional 3,357 shares during the last quarter. Finally, Principal Financial Group Inc. lifted its stake in Core Laboratories by 2.1% in the first quarter. Principal Financial Group Inc. now owns 233,829 shares of the oil and gas company’s stock valued at $3,505,000 after buying an additional 4,733 shares during the last quarter. Hedge funds and other institutional investors own 97.81% of the company’s stock.

Analysts Set New Price Targets

CLB has been the subject of a number of research reports. Citigroup reduced their price objective on Core Laboratories from $16.00 to $13.00 and set a “neutral” rating for the company in a research note on Tuesday, May 13th. Stifel Nicolaus reduced their price objective on Core Laboratories from $13.00 to $12.00 and set a “hold” rating for the company in a research note on Wednesday, July 16th. Wall Street Zen upgraded Core Laboratories from a “sell” rating to a “hold” rating in a research note on Saturday, July 26th. Finally, Zacks Research upgraded Core Laboratories from a “strong sell” rating to a “hold” rating in a research note on Friday, August 15th. Three research analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $12.50.

Core Laboratories Price Performance

Core Laboratories stock opened at $12.47 on Friday. Core Laboratories Inc. has a 12 month low of $9.72 and a 12 month high of $21.83. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.27 and a quick ratio of 1.70. The business has a 50 day simple moving average of $11.47 and a 200-day simple moving average of $12.43. The stock has a market capitalization of $584.48 million, a PE ratio of 20.10, a price-to-earnings-growth ratio of 3.56 and a beta of 1.46.

Core Laboratories (NYSE:CLB) last announced its quarterly earnings data on Wednesday, July 23rd. The oil and gas company reported $0.19 earnings per share for the quarter, topping analysts’ consensus estimates of $0.18 by $0.01. Core Laboratories had a return on equity of 14.15% and a net margin of 5.73%.The firm had revenue of $130.16 million for the quarter, compared to analyst estimates of $129.19 million. During the same quarter in the prior year, the company posted $0.22 earnings per share. Core Laboratories’s quarterly revenue was down .3% on a year-over-year basis. Core Laboratories has set its Q3 2025 guidance at 0.180-0.220 EPS. Equities analysts predict that Core Laboratories Inc. will post 0.96 earnings per share for the current year.

Core Laboratories Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, August 25th. Investors of record on Monday, August 4th were issued a dividend of $0.01 per share. This represents a $0.04 dividend on an annualized basis and a yield of 0.3%. The ex-dividend date of this dividend was Monday, August 4th. Core Laboratories’s dividend payout ratio is currently 6.45%.

Core Laboratories Profile

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.